Strategies for the development of gadolinium-based 'q'-activatable MRI contrast agents

scientific article published on 27 September 2012

Strategies for the development of gadolinium-based 'q'-activatable MRI contrast agents is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/NBM.2870
P932PMC publication ID3586386
P698PubMed publication ID23015370

P2093author name stringAngelique Y Louie
Chuqiao Tu
P2860cites workSpiropyrans and Spirooxazines for Memories and SwitchesQ34107883
Photochromically-controlled, reversibly-activated MRI and optical contrast agentQ36915811
Synthesis and characterization of a redox- and light-sensitive MRI contrast agentQ37183401
Multimodal magnetic-resonance/optical-imaging contrast agent sensitive to NADH.Q37408583
Responsive magnetic resonance imaging contrast agents as chemical sensors for metals in biology and medicineQ37659916
Bioluminescence imaging: progress and applicationsQ37905334
Nanoformulations for molecular MRI.Q38001399
Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles.Q40465620
pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligationQ43692813
High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity.Q55470671
Towards MRI contrast agents responsive to Ca(II) and Mg(II) ions: metal-induced oligomerization of dota-bisphosphonate conjugatesQ57391334
Critical In Vitro Evaluation of Responsive MRI Contrast Agents for Calcium and ZincQ60171689
Smart Magnetic Resonance Imaging Agents that Sense Extracellular Calcium FluctuationsQ60319141
Dual MRI-SPECT agent for pH-mappingQ82583939
[Gd(Try-TTDA)(H2O)]2-: a new MRI contrast agent for copper ion sensingQ83752641
Structure-related variable responses of calcium sensitive MRI probesQ84504469
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and ApplicationsQ28212229
A Novel pH-Sensitive MRI Contrast AgentQ30584261
Strategies for increasing the sensitivity of gadolinium based MRI contrast agentsQ31042317
A smart magnetic resonance contrast agent for selective copper sensingQ31085165
Towards extracellular Ca2+ sensing by MRI: synthesis and calcium-dependent 1H and 17O relaxation studies of two novel bismacrocyclic Gd3+ complexesQ31129489
Facile synthesis and relaxation properties of novel bispolyazamacrocyclic Gd3+ complexes: an attempt towards calcium-sensitive MRI contrast agentsQ31141591
Environment-sensitive and enzyme-sensitive MR contrast agentsQ31162520
Contrast agents: magnetic resonanceQ31162543
A R2/R1 ratiometric procedure for a concentration-independent, pH-responsive, Gd(III)-based MRI agentQ33255681
How to determine the number of inner-sphere water molecules in Lanthanide(III) complexes by 17O NMR spectroscopy. A technical noteQ33282443
Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agentsQ33331622
Copper-responsive magnetic resonance imaging contrast agentsQ33458691
A copper-activated magnetic resonance imaging contrast agent with improved turn-on relaxivity response and anion compatibilityQ33519938
A gadolinium(III) complex with 8-amidequinoline based ligand as copper(II) ion responsive contrast agentQ33757492
Activatable T₁ and T₂ magnetic resonance imaging contrast agentsQ33823740
Bimodal MR-PET agent for quantitative pH imaging.Q33848102
MRI probes for sensing biologically relevant metal ions.Q33852470
Multimodality imaging probes: design and challengesQ33884695
P433issue7
P921main subjectcontrast agentQ6849688
P304page(s)781-787
P577publication date2012-09-27
P1433published inNMR in BiomedicineQ3061252
P1476titleStrategies for the development of gadolinium-based 'q'-activatable MRI contrast agents
P478volume26

Reverse relations

cites work (P2860)
Q47873356Activatable interpolymer complex-superparamagnetic iron oxide nanoparticles as magnetic resonance contrast agents sensitive to oxidative stress.
Q37631684Advances in Monitoring Cell-Based Therapies with Magnetic Resonance Imaging: Future Perspectives
Q37143146Aqueous Lanthanide Chemistry in Asymmetric Catalysis and Magnetic Resonance Imaging.
Q27692546Basic MR relaxation mechanisms and contrast agent design
Q30872930Binary behaviour of an oxidation-responsive MRI nano contrast agent
Q42630057Hydration number: crucial role in nuclear magnetic relaxivity of Gd(III) chelate-based nanoparticles
Q36123378Molecular Magnetic Resonance Imaging of Tumor Response to Therapy.
Q27013727Overcoming the concentration-dependence of responsive probes for magnetic resonance imaging
Q28487307Overhauser-enhanced MRI of elastase activity from in vitro human neutrophil degranulation
Q57768069The evolution of MRI probes: from the initial development to state-of-the-art applications
Q41312049pH-Sensitive MR Responses Induced by Dendron-Functionalized SPIONs

Search more.